MedPath

A Single-center, Randomnized, Evaluator-blinded, Active-controlled Study to evaluate the effectiveness and Safety of Neuramis deep for Correct in Patients with lip and perioral wrinkles.

Phase 1
Conditions
Male and Female age 20 years or older with perioral wrinkle severity scale (PWSS) of moderate to severe
Perioral wrinkle
Registration Number
TCTR20231008002
Lead Sponsor
Medyceles Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Male and Female age 20 years old or older
2. Perioral wrinkle severity scale (PWSS) of moderate to severe level
3. Consent in participate in the project

Exclusion Criteria

1. Previous laser treatment 6 months prior
2. Previous mesotherapy treatment 3 months prior
3. Previous botulinum toxin 6 months prior
4. Previous biostimulator injection 3 months prior
5. History of allergy to anesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PWSS 3 months PWSS score measurement
Secondary Outcome Measures
NameTimeMethod
PWSS 1 month PWSS score measurement ,PWSS 2 months PWSS score measurement ,GAIS 1, 2, 3, 6 months GAIS measurement by physician,Wrinkle and Texture 0, 1, 2, 3, 6 months Antera,Volume change 0, 1, 2, 3, 6 months Vectra program
© Copyright 2025. All Rights Reserved by MedPath